TSI and Its Relationship With Graves' Disease Relapse

Clinical trial NCT05713097 · COMPLETED

Trial details

NCT number: NCT05713097
Sponsor: University of Medicine and Pharmacy at Ho Chi Minh City
Status: COMPLETED
Study type: OBSERVATIONAL

Graves Disease Immunoglobulin Anti-Thyroid Antibodies Disorder

Start date: 2022-01-02
Primary completion: 2022-08-31
Enrollment: 352

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.